Claritev (CTEV) News
NYSE: CTEVConsumer DiscretionaryBusiness ServicesUSD
18.28-0.75 (-3.94%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CTEV news summary
We found 8 recent headlines mentioning Claritev (CTEV): 1 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, CTEV is down 3.94% at $18.28. The most recent story, "Claritev Corporation Announces Participation in Upcoming Events", was published by GlobeNewswire on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Claritev headlines
- Claritev Corporation Announces Participation in Upcoming EventsMCLEAN, Va., Nov. 20, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a healthcare technology, data, and insights company, today announced that members of…GlobeNewswire
- Claritev Corp (CTEV) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Claritev Corporation Q3 Loss Decreases(RTTNews) - Claritev Corporation (CTEV) announced Loss for third quarter of -$61.78 millionNasdaqCTEV, HEI.A
- Claritev Corporation Reports Third Quarter 2026 ResultsMCLEAN, Va., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable,…GlobeNewswire
- Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumMCLEAN, Va., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that members of its…GlobeNewswire
- Claritev Introduces Transparency-Based Pricing, Turning Complex Public Market Data into Actionable Reimbursement IntelligenceClaritev launches AI-enabled Transparency-Based Pricing, turning public healthcare pricing data into actionable reimbursement intelligence.GlobeNewswire
- Claritev Appoints Jennifer Main to its Board of DirectorsBoard gains deep public sector healthcare and financial leadership expertise to support Claritev's growth strategy Board gains deep public sector healthcare and financial leadership expertise to…GlobeNewswire
- Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?TEM's strong data licensing growth, AI-driven innovations and rising shares favor holding the stock, but premium valuation and reimbursement risks warrant caution.NasdaqTEM, IRTC, CTEV